Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gilead Sciences resolves FDA warning letter
Yahoo/AP
Thursday, August 11, 2011 - 11:20am
tags:
FDA, warnings, Gilead, antifungals, AmBisome
Par, Actavis Group Sued by Avanir Over Nuedexta Patents
Bloomberg
Thursday, August 11, 2011 - 11:17am
tags:
Par, Actavis, Avanir, patents, generics, Nuedexta, PBA
MAP Pharmaceuticals issued migraine treatment patent
Bizjournals.com
Thursday, August 11, 2011 - 11:14am
tags:
MAP Pharmaceuticals, patents, migraines
Venture Investing In Biotech Continues To Drop
Pharmalot
Thursday, August 11, 2011 - 11:13am
tags:
biotech, venture capital
Pfizer has begun payouts to victims, families over fatal 1996 meningitis drug study in Nigeria
Yahoo/AP
Thursday, August 11, 2011 - 11:12am
tags:
Nigeria, settlements, meningitis, Pfizer, Trovan
Analyst sees low physician expectations for new Gilead HIV treatment Complera
Yahoo/AP
Thursday, August 11, 2011 - 11:10am
tags:
Gilead, HIV, Complera, JNJ, Atripla, Bristol-Myers Squibb
Paladin makes hostile bid for Afexa
Fierce Biotech
Wednesday, August 10, 2011 - 8:36pm
tags:
Afexa, Paladin, hostile bid, M&A
Forest Labs says firms support its board nominees
Yahoo/AP
Wednesday, August 10, 2011 - 7:37pm
tags:
Forest Labs, Carl Icahn
Apricus Biosciences: A Victim of Market Hysteria
Seeking Alpha
Wednesday, August 10, 2011 - 7:35pm
tags:
Apricus Biosciences, NexACT
Orexigen Revisited: Chances for Contrave Approval Seem Slim
Seeking Alpha
Wednesday, August 10, 2011 - 5:29pm
tags:
Contrave, Orexigen, obesity
J&J, Gilead HIV Drug Wins FDA Approval
Bloomberg
Wednesday, August 10, 2011 - 5:28pm
tags:
Gilead, JNJ, Complera, HIV, FDA, Edurant, Truvada
Merck Vioxx Lawyers Get More Fees After Filing Objections
Bloomberg
Wednesday, August 10, 2011 - 5:25pm
tags:
Merck, Vioxx
Icagen 2Q net loss increases
Bizjournals.com
Wednesday, August 10, 2011 - 5:24pm
tags:
earnings, Icagen
Amarin Reports Second Quarter 2011 Results
Yahoo
Wednesday, August 10, 2011 - 10:51am
tags:
Amarin, earnings
DOJ Subpoena May Rattle Old Skeletons in Merck’s Closet
BNET Pharma
Wednesday, August 10, 2011 - 10:50am
tags:
hepatitis C, melanoma, cancer, Intron A, Temodar, DOJ, PegIntron, Merck
A Former Pharma Ghostwriter Speaks Out
Forbes
Wednesday, August 10, 2011 - 10:48am
tags:
Ghostwriting
Drug Maker Dividend Stocks With Strong Growth Prospects
Seeking Alpha
Wednesday, August 10, 2011 - 10:47am
tags:
Pfizer, Merck, Bristol-Myers Squibb, Novartis, Takeda, Sanofi, Eli Lilly, GSK, Roche, AstraZeneca, dividends
Johnson & Johnson Reaches Agreement With U.S. on Risperdal Criminal Charge
Bloomberg
Wednesday, August 10, 2011 - 10:44am
tags:
off-label, antipsychotics, Risperdal, JNJ
Yervoy may face Roche rival sooner than expected
Fierce Pharma
Tuesday, August 9, 2011 - 6:29pm
tags:
Bristol-Myers Squibb, Zelboraf, melanoma, Yervoy, Roche
Merck, Pfizer Among Cash Stashers as Markets Gyrate
Motley Fool
Tuesday, August 9, 2011 - 6:28pm
tags:
Pfizer, Merck, stocks

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.